Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Accured Expenses (2018 - 2026)

Viemed Healthcare filings provide 8 years of Change in Accured Expenses readings, the most recent being -$1.3 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 406.93% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $255000.0, a 91.07% decrease, with the full-year FY2025 number at $255000.0, down 91.07% from a year prior.
  • Change in Accured Expenses hit -$1.3 million in Q4 2025 for Viemed Healthcare, down from $3.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.6 million in Q3 2025 to a low of -$3.7 million in Q2 2021.
  • Median Change in Accured Expenses over the past 5 years was $73500.0 (2021), compared with a mean of $329900.0.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 3559.55% in 2022 and later tumbled 406.93% in 2025.
  • Viemed Healthcare's Change in Accured Expenses stood at -$311000.0 in 2021, then crashed by 99.68% to -$621000.0 in 2022, then soared by 240.58% to $873000.0 in 2023, then tumbled by 50.4% to $433000.0 in 2024, then tumbled by 406.93% to -$1.3 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$1.3 million (Q4 2025), $3.6 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.